Cover Image
市場調查報告書

神經血管支架:醫療設備的開發平台評估

Neurovascular Stents - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 358227
出版日期 內容資訊 英文 43 Pages
訂單完成後即時交付
價格
Back to Top
神經血管支架:醫療設備的開發平台評估 Neurovascular Stents - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年05月23日 內容資訊: 英文 43 Pages
簡介

本報告提供全球神經血管支架市場上主要的開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品功能·特性比較分析 (臨床實驗的各進展階段) ,還有主要企業簡介及代表性產品,彙整近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 神經血管支架概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 神經血管支架的企業:各臨床實驗階段的開發中產品
  • 神經血管支架:各臨床實驗階段的開發中產品

第5章 神經血管支架市場:企業·產品概要

  • Aneuclose LLC
  • Apeliotus Technologies
  • DePuy Synthes, Inc.
  • Gaudi Vascular, Inc.
  • InspireMD, Inc.
  • MicroVention, Inc.
  • NeuroSigma, Inc.
  • NSVascular, Inc.
  • Oxford Endovascular Limited
  • Palmaz Scientific, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology

第6章 神經血管支架市場:目前的趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0190EPD

GlobalData's Medical Devices sector report, "Neurovascular Stents - Medical Devices Pipeline Assessment, 2016" provides an overview of Neurovascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurovascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Neurovascular Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Neurovascular Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Neurovascular Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Neurovascular Stents Overview

3. Products under Development

  • 3.1. Neurovascular Stents - Pipeline Products by Stage of Development
  • 3.2. Neurovascular Stents - Pipeline Products by Territory
  • 3.3. Neurovascular Stents - Pipeline Products by Regulatory Path
  • 3.4. Neurovascular Stents - Pipeline Products by Estimated Approval Date
  • 3.5. Neurovascular Stents - Ongoing Clinical Trials

4. Neurovascular Stents - Pipeline Products under Development by Companies

  • 4.1. Neurovascular Stents Companies - Pipeline Products by Stage of Development
  • 4.2. Neurovascular Stents - Pipeline Products by Stage of Development

5. Neurovascular Stents Companies and Product Overview

  • 5.1. Aneuclose LLC Company Overview
    • 5.1.1. Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Apeliotus Technologies Company Overview
    • 5.2.1. Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. DePuy Synthes, Inc. Company Overview
    • 5.3.1. DePuy Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Gaudi Vascular, Inc. Company Overview
    • 5.4.1. Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. InspireMD, Inc. Company Overview
    • 5.5.1. InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. MicroVention, Inc. Company Overview
    • 5.6.1. MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. NeuroSigma, Inc. Company Overview
    • 5.7.1. NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. NSVascular, Inc. Company Overview
    • 5.8.1. NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Oxford Endovascular Limited Company Overview
    • 5.9.1. Oxford Endovascular Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Palmaz Scientific, Inc. Company Overview
    • 5.10.1. Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.11.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

6. Neurovascular Stents- Recent Developments

  • 6.1. May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016
  • 6.2. Apr 27, 2016: Bard Announces First Quarter Results
  • 6.3. Feb 16, 2016: Codman Neuro Announces Launch Of Codman Enterprise 2
  • 6.4. Jan 29, 2016: Bard Announces Fourth Quarter Results
  • 6.5. Oct 22, 2015: Bard Announces Third Quarter Results
  • 6.6. Jul 23, 2015: Bard Announces Second Quarter Results
  • 6.7. Jul 21, 2015: FDA Issues Warning Letter To C. R. Bard
  • 6.8. Jul 17, 2015: EndoShape Raises USD1.2 Million in Venture Financing
  • 6.9. Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean
  • 6.10. Jul 03, 2015: MicroPort NeuroTech Attends CSA&TISC to Promote APOLLO

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Neurovascular Stents - Pipeline Products by Stage of Development
  • Table 2: Neurovascular Stents - Pipeline Products by Territory
  • Table 3: Neurovascular Stents - Pipeline Products by Regulatory Path
  • Table 4: Neurovascular Stents - Pipeline Products by Estimated Approval Date
  • Table 5: Neurovascular Stents - Ongoing Clinical Trials
  • Table 6: Neurovascular Stents Companies - Pipeline Products by Stage of Development
  • Table 7: Neurovascular Stents - Pipeline Products by Stage of Development
  • Table 8: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Aneurysm Occlusion Saddle - Product Status
  • Table 10: Aneurysm Occlusion Saddle - Product Description
  • Table 11: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Polymer Stent for Cerebral Aneurysms - Product Status
  • Table 13: Polymer Stent for Cerebral Aneurysms - Product Description
  • Table 14: DePuy Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Covered Stent - Product Status
  • Table 16: Covered Stent - Product Description
  • Table 17: Next Generation Balloon Expandable Stent - Product Status
  • Table 18: Next Generation Balloon Expandable Stent - Product Description
  • Table 19: Self-Expanding Stent - Product Status
  • Table 20: Self-Expanding Stent - Product Description
  • Table 21: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Intracranial Stent - Product Status
  • Table 23: Intracranial Stent - Product Description
  • Table 24: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: NVGuard Neurovascular - Product Status
  • Table 26: NVGuard Neurovascular - Product Description
  • Table 27: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: FRED Flow-Diverting Stent - Product Status
  • Table 29: FRED Flow-Diverting Stent - Product Description
  • Table 30: MicroVention, Inc. - Ongoing Clinical Trials Overview
  • Table 31: FRED Flow-Diverting Stent - Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms
  • Table 32: NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Thin Film Nitinol Flow Diverting Stent - Product Status
  • Table 34: Thin Film Nitinol Flow Diverting Stent - Product Description
  • Table 35: NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Flow-Diverting TFN Stent - Product Status
  • Table 37: Flow-Diverting TFN Stent - Product Description
  • Table 38: Oxford Endovascular Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Oxiflow - Product Status
  • Table 40: Oxiflow - Product Description
  • Table 41: Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Micro Neuro-Stent - Product Status
  • Table 43: Micro Neuro-Stent - Product Description
  • Table 44: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Flow Diversion Intracranial Stent - Product Status
  • Table 46: Flow Diversion Intracranial Stent - Product Description
  • Table 47: Glossary

List of Figures

  • Figure 1: Neurovascular Stents - Pipeline Products by Stage of Development
  • Figure 2: Neurovascular Stents - Pipeline Products by Territory
  • Figure 3: Neurovascular Stents - Pipeline Products by Regulatory Path
  • Figure 4: Neurovascular Stents - Pipeline Products by Estimated Approval Date
  • Figure 5: Neurovascular Stents - Ongoing Clinical Trials
Back to Top